MétaCan
Menu
Back to cohort
Record W4282591735 · doi:10.1038/s41587-022-01342-x

Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression

2022· article· en· W4282591735 on OpenAlexafffund
Shaolong Cao, Jennifer Wang, Shuangxi Ji, Yang Peng, Yaoyi Dai, Shuai Guo, Matthew D. Montierth, John Paul Shen, Xiao Hong Zhao, Jingxiao Chen, Jaewon J. Lee, Paola A. Guerrero, Nicholas Spetsieris, Nikolai Engedal, Sinja Taavitsainen, Kaixian Yu, Julie Livingstone, Vinayak Bhandari, Shawna M. Hubert, Najat C. Daw, P. Andrew Futreal, Eleni Efstathiou, Bora Lim, Andrea Viale, Jianjun Zhang, Matti Nykter, Bogdan Czerniak, Powel H. Brown, Charles Swanton, Pavlos Msaouel, Anirban Maitra, Scott Kopetz, Peter J. Campbell, Terence P. Speed, Paul C. Boutros, Hongtu Zhu, Alfonso Urbanucci, Jonas Demeulemeester, Peter Van Loo, Wenyi Wang

Bibliographic record

VenueNature Biotechnology · 2022
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer Genomics and Diagnostics
Canadian institutionsUniversity of Toronto
FundersStand Up To CancerUniversity of Texas MD Anderson Cancer CenterEMD SeronoNational Institutes of HealthCRUK Lung Cancer Centre of ExcellenceKadoorie Charitable FoundationNovo Nordisk FondenSuomen KulttuurirahastoAcademy of FinlandSyöpäjärjestötGenentechAstraZenecaEuropean CommissionVlaamse regeringNational Institute for Health and Care ResearchRosetrees TrustNateraMirati TherapeuticsMedical Research CouncilAmerican Association for Cancer ResearchServierHope FoundationLes Laboratories Pierre FabreIpsenFonds Wetenschappelijk OnderzoekArray BioPharmaJazz PharmaceuticalsFrancis Crick InstituteGlaxoSmithKlineCancer Prevention and Research Institute of TexasKreftforeningenNovo NordiskLUNGevity FoundationEntertainment Industry FoundationGilead SciencesAmgenInvitaeOno PharmaceuticalCancer Research UKU.S. Department of DefenseEli Lilly and CompanyRoyal SocietyKhalifa Bin Zayed Al Nahyan FoundationBristol-Myers SquibbNational Cancer InstituteUniversity College LondonWellcome TrustJohns Hopkins UniversityGateway for Cancer ResearchWelch FoundationDaiichi Sankyo EuropeBC Cancer AgencyInnovent BiologicsPfizerMEI PharmaExelixisSanofiBreast Cancer Research Foundation
KeywordsBiologyCancerTranscriptomeMessenger RNAPhenotypeTumor progressionDiseaseGene expressionGeneCancer researchGeneticsPathologyMedicine

Abstract

fetched live from OpenAlex

Single-cell RNA sequencing studies have suggested that total mRNA content correlates with tumor phenotypes. Technical and analytical challenges, however, have so far impeded at-scale pan-cancer examination of total mRNA content. Here we present a method to quantify tumor-specific total mRNA expression (TmS) from bulk sequencing data, taking into account tumor transcript proportion, purity and ploidy, which are estimated through transcriptomic/genomic deconvolution. We estimate and validate TmS in 6,590 patient tumors across 15 cancer types, identifying significant inter-tumor variability. Across cancers, high TmS is associated with increased risk of disease progression and death. TmS is influenced by cancer-specific patterns of gene alteration and intra-tumor genetic heterogeneity as well as by pan-cancer trends in metabolic dysregulation. Taken together, our results indicate that measuring cell-type-specific total mRNA expression in tumor cells predicts tumor phenotypes and clinical outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.400

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.003
GPT teacher head0.243
Teacher spread0.240 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations76
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueNature BiotechnologySame topicCancer Genomics and DiagnosticsFrench-language works237,207